(Q77293823)
Statements
Randomized phase II study of fludarabine + cytosine arabinoside + idarubicin +/- all-trans retinoic acid +/- granulocyte colony-stimulating factor in poor prognosis newly diagnosed acute myeloid leukemia and myelodysplastic syndrome (English)
Estey EH
Thall PF
Pierce S
Cortes J
Beran M
Kantarjian H
Keating MJ
Andreeff M